Corporate Banner
Satellite Banner
LIMS & ELNs
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit

Published: Wednesday, March 13, 2013
Last Updated: Wednesday, March 13, 2013
Bookmark and Share
Genedata Expressionist will be demonstrated as a platform for automating and standardizing protein characterization that helps eliminate data analysis bottlenecks

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, has announced that Genedata Expressionist® for Mass Spectrometry will be showcased in the "Establishing Analytical Support for Manufacturing" session of the 2013 Biotherapeutics Analytical Summit. The session will present workflows for analyzing glycosylation events using Genedata Expressionist. The Genedata platform automates and standardizes protein characterization within a single high-throughput system to significantly improve sample throughput and result reproducibility. The presentation will be given on March 13 (Royal Sonesta Harbor Court) by Dr. Monica Lane from Genzyme.
 
Genedata Expressionist for Mass Spectrometry is a comprehensive, enterprise software solution that efficiently manages, processes and analyzes massive amounts of mass spectrometry data. With a proven track record of success in the biopharmaceutical industry, it analyzes mass spectrometry data for a variety of tasks related to protein characterization, such as identification and quantification of Post Translational Modifications (PTMs). Instrument-agnostic, Genedata Expressionist integrates and analyzes raw data from any mass spectrometry technology and vendor, serving as an integration platform for analytical labs using a variety of mass spectrometry instruments. By automating routine data analysis, Genedata Expressionist has been successfully applied along the biopharmaceutical R&D and manufacturing pipelines to improve quality control and sample analytics.
 
Standardized Platform Accelerates Research - Reduces Research Costs
Thriving on large experimental data sets, Genedata Expressionist has been proven to reduce data analysis time from weeks to a few hours. By enhancing productivity, improving data quality and accelerating time-to-market, Genedata Expressionist contributes to significant cost savings by several orders of magnitude.
 
The Genedata session at the Biotherapeutics Analytical Summit will demonstrate how leading pharmaceutical companies have successfully automated the analysis of mass spectrometry data for site-specific glycosylation of biopharmaceuticals. The qualitative and quantitative analysis of glycosylation presents data analysis challenges, which Genedata Expressionist solves with a platform for fast comparability of biotherapeutic batches, ensuring consistent manufacturing processes.
 
"Genedata Expressionist for Mass Spectrometry provides our customers with a highly valuable platform that automates the processing of mass spec data in the context of characterizing biotherapeutics," noted Dr. Othmar Pfannes, CEO of Genedata. "In particular, our solution's innovative visualizations enable quick and reproducible decision making. The elimination of data analysis bottlenecks generates tremendous cost and time savings, making Genedata Expressionist nothing short of a killer application for the bioanalytics industry," continued Pfannes.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GSK Implements Genedata Biologics as Antibody Discovery Platform
Genedata Biologics integrates GlaxoSmithKline's Biopharm Discovery workflows across multiple Biopharm R&D groups and sites
Thursday, June 12, 2014
Genedata Showcases Integrated Analysis & Image Management Solution for Phenotypic Screening
Regardless of instrument or application, Genedata Screener® for High Content Screening enables time-efficient workflow for analysis of high-content experiments
Friday, February 21, 2014
Genedata Announces New Data Analysis Platform for Next-Gen Oncology Drug Discovery
AstraZeneca and Genedata detail a data analysis platform for compound combination experiments in oncology and other therapeutic areas
Monday, February 03, 2014
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Chooses Genedata Expressionist for Oncology Research
Leading clinical-research institute of the Robert Bosch Stiftung uses Genedata Expressionist for managing, processing, and interpreting clinical NGS data
Monday, January 27, 2014
Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization
Genedata Selector platform to manage, analyze, and integrate complex microbial genomes and strains will be showcased in 5th Annual NGS Conference Poster Session
Saturday, November 23, 2013
Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
Genedata Biologics will be implemented at multiple Sanofi R&D sites and departments to improve biologics discovery throughput and process efficiency.
Sunday, November 10, 2013
Evonik and Genedata broaden their collaboration with the Genedata Selector biotechnology data management platform
Genomic strain data management solution supports Evonik growth in biotechnology
Sunday, September 22, 2013
AB SCIEX, Genedata and LECO Announce Partnership
New collaborative software system will enable metabolomics researchers to comprehensively process and analyze experimental data across different GC/MS and LC/MS platforms.
Tuesday, July 02, 2013
Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
Genedata collaborates with leading European institutions on the development of blood tests for early detection of major female cancers based on epigenetic markers
Saturday, April 06, 2013
Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
Global leader in drug discovery advances targeted proteomics and metabolomics with extended use of Genedata Expressionist®
Sunday, February 10, 2013
Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
More than half of the top 25 pharmaceutical companies now use Genedata Screener® to support plate-based screening, including High Content, Label-free, and Ion Channel Screening
Sunday, January 20, 2013
Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
carcinoGENOMICS and other EU-funded research consortia help Genedata advance software platform
Friday, December 28, 2012
Genedata Biologics for Streamlined Protein Engineering at PEGS Europe
UCB Pharma and Genedata will showcase data management and workflow system that captures production and characterization data for biotherapeutics and reagents
Sunday, November 11, 2012
UCB Pharma Advances Next-Generation Antibody Discovery with Genedata Biologics
Leader in protein therapeutics development extends use of Genedata Biologics for next-generation antibody-based therapeutics R&D
Thursday, September 20, 2012
Genedata and Insilico Biotechnology Integrate Industrial Biotechnology Platforms
Integrative bioinformatics platform will streamline and accelerate production strain optimization for fermentation-based applications
Thursday, September 20, 2012
Scientific News
Exploring Living cells
JPK reports the exploration of living cells using nanoscale and single molecule techniques through the application of scanning probe microscopy.
The Perfect Partnership: Research & Industry; Software & Instrumentation. It really starts to come together at ASMS 2015
Collaboration and knowledge-sharing were evident everywhere: on the bus, in the hallways and in the bars. This article aims to capture this theme and share with you some of the fruits of this coming together of science and industry.
Designing New Pain Relief Drugs
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
Antibody Pries Loose Bacteria’s Grip
Study finds novel method of improving antibody efficacy.
CLAIRE Brings Electron Microscopy to Soft Materials
CLAIRE works by essentially combining the best attributes of optical and scanning electron microscopy into a single imaging platform.
Sample & Analysis Tracking in Oncogenomic Experiments
The study outlines Onco-STS, a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.
Pittcon Announces Wide Variety of Short Courses
Courses range from beginner and intermediate to advanced levels.
Ultra-enriched Silicon Paves the Road to Quantum Computing
Using a relatively straightforward technique, a team of NIST researchers has created what may be the most highly enriched silicon currently being produced.
BioClinica and Rutgers University Announce Research Project Results
Scientific Partnership Aims to Expand Automation of Clinical Trial Image Data Analysis
Leading Japanese CRO Standardizes on Thermo Scientific Watson LIMS
JCL Bioassay uses Thermo Scientific Watson LIMS to optimize communication, data management and quality control during U.S. expansion.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!